401 related articles for article (PubMed ID: 8600112)
1. Brachytherapy or electron beam boost in conservation therapy of carcinoma of the breast: a nonrandomized comparison.
Perez CA; Taylor ME; Halverson K; Garcia D; Kuske RR; Lockett MA
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):995-1007. PubMed ID: 8600112
[TBL] [Abstract][Full Text] [Related]
2. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.
Reitsamer R; Peintinger F; Kopp M; Menzel C; Kogelnik HD; Sedlmayer F
Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843
[TBL] [Abstract][Full Text] [Related]
3. External beam irradiation plus (192)Ir implant after breast-preserving surgery in women with early breast cancer.
Moreno F; Guedea F; Lopez Y; Ferrer F; Gutierrez C; Petriz L; Pera J
Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):757-65. PubMed ID: 11020573
[TBL] [Abstract][Full Text] [Related]
4. 5-year results of pulsed dose rate brachytherapy applied as a boost after breast-conserving therapy in patients at high risk for local recurrence from breast cancer.
Harms W; Krempien R; Hensley FW; Berns C; Fritz P; Wannenmacher M
Strahlenther Onkol; 2002 Nov; 178(11):607-14. PubMed ID: 12426671
[TBL] [Abstract][Full Text] [Related]
5. Early breast cancer: influence of type of boost (electrons vs iridium-192 implant) on local control and cosmesis after conservative surgery and radiation therapy.
Touboul E; Belkacemi Y; Lefranc JP; Uzan S; Ozsahin M; Korbas D; Buffat L; Balosso J; Pene F; Blondon J
Radiother Oncol; 1995 Feb; 34(2):105-13. PubMed ID: 7597208
[TBL] [Abstract][Full Text] [Related]
6. Does delay in breast irradiation following conservative breast surgery in node-negative breast cancer patients have an impact on risk of recurrence?
Vujovic O; Perera F; Dar AR; Stitt L; Yu E; Voruganti SM; Truong PT
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):869-74. PubMed ID: 9531372
[TBL] [Abstract][Full Text] [Related]
7. Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience.
Trombetta M; Julian T; Bhandari T; Werts ED; Miften M; Parda D
Brachytherapy; 2008; 7(1):29-36. PubMed ID: 18201940
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of Breast Cancer Patients Treated with Accelerated Partial Breast Irradiation Via Multicatheter Interstitial Brachytherapy: The Pooled Registry of Multicatheter Interstitial Sites (PROMIS) Experience.
Kamrava M; Kuske RR; Anderson B; Chen P; Hayes J; Quiet C; Wang PC; Veruttipong D; Snyder M; Jeffrey Demanes D
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S404-11. PubMed ID: 25916980
[TBL] [Abstract][Full Text] [Related]
9. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.
Touboul E; Buffat L; Belkacémi Y; Lefranc JP; Uzan S; Lhuillier P; Faivre C; Huart J; Lotz JP; Antoine M; Pène F; Blondon J; Izrael V; Laugier A; Schlienger M; Housset M
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):25-38. PubMed ID: 9989511
[TBL] [Abstract][Full Text] [Related]
10. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.
Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Uter W; Strnad V;
Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198
[TBL] [Abstract][Full Text] [Related]
11. The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation.
Fowble B; Hanlon AL; Patchefsky A; Freedman G; Hoffman JP; Sigurdson ER; Goldstein LJ
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):105-15. PubMed ID: 9747827
[TBL] [Abstract][Full Text] [Related]
12. Early-stage bilateral breast cancer treated with breast-conserving surgery and definitive irradiation: the University of Pennsylvania experience.
Fung MC; Schultz DJ; Solin LJ
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):959-67. PubMed ID: 9276360
[TBL] [Abstract][Full Text] [Related]
13. Conservation therapy in T1-T2 breast cancer: past, current issues, and future challenges and opportunities.
Perez CA
Cancer J; 2003; 9(6):442-53. PubMed ID: 14740972
[TBL] [Abstract][Full Text] [Related]
14. IOERT as anticipated tumor bed boost during breast-conserving surgery after neoadjuvant chemotherapy in locally advanced breast cancer--results of a case series after 5-year follow-up.
Fastner G; Reitsamer R; Ziegler I; Zehentmayr F; Fussl C; Kopp P; Peintinger F; Greil R; Fischer T; Deutschmann H; Sedlmayer F
Int J Cancer; 2015 Mar; 136(5):1193-201. PubMed ID: 24995409
[TBL] [Abstract][Full Text] [Related]
15. Boost irradiation of breast carcinoma: teletherapy vs. brachytherapy.
Berberich W; Schnabel K; Berg D; Lamprecht E
Eur J Obstet Gynecol Reprod Biol; 2001 Feb; 94(2):276-82. PubMed ID: 11165739
[TBL] [Abstract][Full Text] [Related]
16. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
Trombetta M; Julian TB; Werts DE; McWilliams W; Kim Y; Miften M; Parda D
Am J Clin Oncol; 2009 Jun; 32(3):314-8. PubMed ID: 19451803
[TBL] [Abstract][Full Text] [Related]
17. Breast conservation therapy for early stage breast carcinoma with outstanding 10-year locoregional control rates: a case for aggressive therapy to the tumor bearing quadrant.
Schmidt-Ullrich RK; Wazer DE; DiPetrillo T; Marchant DJ; Smith TJ; Safaii H; Schmid C; Homer MJ
Int J Radiat Oncol Biol Phys; 1993 Oct; 27(3):545-52. PubMed ID: 8226147
[TBL] [Abstract][Full Text] [Related]
18. Ten-year results in 1070 patients with stages I and II breast cancer treated by conservative surgery and radiation therapy.
Mansfield CM; Komarnicky LT; Schwartz GF; Rosenberg AL; Krishnan L; Jewell WR; Rosato FE; Moses ML; Haghbin M; Taylor J
Cancer; 1995 May; 75(9):2328-36. PubMed ID: 7712444
[TBL] [Abstract][Full Text] [Related]
19. Survival and local control rates of triple-negative breast cancer patients treated with boost-IOERT during breast-conserving surgery.
Fastner G; Hauser-Kronberger C; Moder A; Reitsamer R; Zehentmayr F; Kopp P; Fussl C; Fischer T; Deutschmann H; Sedlmayer F
Strahlenther Onkol; 2016 Jan; 192(1):1-7. PubMed ID: 26403912
[TBL] [Abstract][Full Text] [Related]
20. Dose-volume analysis of radiotherapy for T1N0 invasive breast cancer treated by local excision and partial breast irradiation by low-dose-rate interstitial implant.
Lawenda BD; Taghian AG; Kachnic LA; Hamdi H; Smith BL; Gadd MA; Mauceri T; Powell SN
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):671-80. PubMed ID: 12788172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
